Main Article Content


Serological identification and blood pictures were done for specific IgM and IgG.10% of cases were positive IgM of Toxoplasmosis because have 10 IU/ml (mean) in comparison with control group were 0.11 IU/ml (mean). On other hand 20% of diagnosed cases were positive IgG of Toxoplasmosis because have 11 IU/ml .Two cases were followed for their history one from group IgM and other IgG , first one suffered from three abortion and now have five child three of them healthy while two have congenital defects. Second case (IgG positive ) have four abortion and now have three child , two healthy and one have congenital defect. Blood picture reveal 40% suffered from Normocytic anemia , these cases classified to three groups , first Toxoplasma group 30% (positive in ELISA test). Second group (Unknown causes), these cases not only normocytic anemia also have high total leukocytes 17 x10 (mean) and high MCV (103 ft). Third group have low MCV 78ft.


Toxoplasmosis Neonatal Infection Toxoplasma Gondii

Article Details

How to Cite
Assit, K. A. D. ., Talib, R. A., & Falah, H. (2021). Serological and Hematological Study of Toxoplasmosis in Blood of Newly Born Babies. Medical Science Journal for Advance Research, 2(3), 102–106.


  1. Dubey, J.P. (1995). Toxoplasma gondii. Medical microbiology Chapter 84:pp:350.
  2. Figueiro-Filho, E., Lopes, A., Senefonte, F., Souza,Junior, V.& Botelho, C. (2005). Toxoplasma gondii: Study the Frequency of vertical transmission diagnosis of Materno-fetalis. Rev.Bras. Ginecol. Obestet.27:442-9.
  3. Foulon, W.(1992).Congenital Toxoplasmosis: is screening Desirable? Scand. J. Infect. Dis. 84(Suppl):11-7.
  4. Gavinet, M.F. Robert,F. Firtion, G. et al.(1997).congenital Toxoplasmosis due to maternal reinfection during pregnancy. J. Clin. Microbiol. 35: 1276-7.
  5. Guerina, al (1994). Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The new England regional Toxoplasmoșis working group.N. Engl. J.Med. 330:1858-1863
  6. Gilbert, R. and Gras, L.(2003).Effect of timing and type of treatment on the risk of mother to child transmission of T. gondi
  7. European multicenter study on congenital Toxoplasmosis, V.(110). PP:112-120. Jenum, P. Stray-Pedersen, B.Melby, K. Kapperud, G. Whitelaw, A. Eskid, A. Eng.J.(1998). Incidence of T.gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J. Clin. Microbiol. 36:(10),2900-6.
  8. Jones, J.L. Lopez, A. Wilson, M. Schulkin, J. Gibbs, R.(2001). Congenital Toxoplasmosis: A review.Obstet. Surv.56:296-305.
  9. Jones, J.L. Lopez, A. | Wilson, M. (2003).Congenital Toxoplasmosis. Am.Fam. Physican . 67: 2131-8.
  10. Matrin, F.(2000). Congenital Toxoplasmosis: Value of antenatal screening current prenatal treatment. Rev. Obste. Gynecol.1:46-51.
  11. Marua, J.(2013). Bloody serological study of toxoplasmosis in pregnant women and newlyborn babies in Diwanyia, MSc thesis / Alqadisyia University.
  12. Moura, F.L. Amendoeira, M.R. Bastos, O.M. Mattos, D.P. Fonseca, A.B. Nicolau, J. L.(2013). Prevalence and Risk factors for T.gondii infection among pregnant and postpartum women attended at public health care facilities in the city of Niteroi state of Rio de Janeiro, Brazil, Rev. Soc. Bras. Med. Trop.46:200-7.
  13. Nimri, L. Pelloux, H. and Elkhatib, H. (2004). Detection of T. gondii and specific antibodies in high-risk pregnant women. Am. J. Trop. Med. Hyg. 71 (6):831-5.
  14. Paquet, C. Yudin, M.(2013). Toxoplasmosis in pregnancy: Prevention screening and treatment. J. Obest. Gyna, Can. 35: 78-9. 15-
  15. Remington, J. Mcleod, R. Wilson, C. Desmonts, G.(2010). Infectious diseases of the fetus and newborn infant. Text book, 17th thed. Pennsylvania: Elsevier. pp:918-1041.
  16. Robbins, S. Cotran,R. Kumar, V. (2008). Pathologic Bases of disease. 9th ed. Saunders com., p.373.
  17. Schmidt, S. Mazzelia, M. Nixon, R. Mathews, P. (2013). Ab measurement by ELISA methods in Molecular Biology , 849: 507-27.